Clinical Trial Update: Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS [Phase 1]

View source ↗

Summary

This clinical trial update notes a Phase 1 study of CD33 FPBMC in patients with measurable residual disease positive acute myeloid leukemia or myelodysplastic s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Myeloproliferative Neoplasm
• Myelodysplastic Syndromes

Drugs mentioned

• CD33 FPBMC

Snippet

Sponsor: University of Virginia | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 1 | Status: RECRUITING